ATE171186T1 - Neue steroid-zwischenprodukte und verfahren zu ihrer herstellung - Google Patents
Neue steroid-zwischenprodukte und verfahren zu ihrer herstellungInfo
- Publication number
- ATE171186T1 ATE171186T1 AT93904484T AT93904484T ATE171186T1 AT E171186 T1 ATE171186 T1 AT E171186T1 AT 93904484 T AT93904484 T AT 93904484T AT 93904484 T AT93904484 T AT 93904484T AT E171186 T1 ATE171186 T1 AT E171186T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- carbonate
- hydroxy
- pct
- prepared
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 239000013067 intermediate product Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000002585 base Substances 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 239000003246 corticosteroid Substances 0.000 abstract 2
- 229960001334 corticosteroids Drugs 0.000 abstract 2
- -1 trialkylsilyl chloride Chemical compound 0.000 abstract 2
- SNMVJSSWZSJOGL-PLOWYNNNSA-N 9alpha-hydroxyandrost-4-en-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@@]3(O)CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 SNMVJSSWZSJOGL-PLOWYNNNSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000004703 alkoxides Chemical class 0.000 abstract 1
- 150000001361 allenes Chemical class 0.000 abstract 1
- 229960002537 betamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 abstract 1
- 229910003002 lithium salt Inorganic materials 0.000 abstract 1
- 159000000002 lithium salts Chemical class 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82669592A | 1992-01-28 | 1992-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE171186T1 true ATE171186T1 (de) | 1998-10-15 |
Family
ID=25247277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93904484T ATE171186T1 (de) | 1992-01-28 | 1993-01-26 | Neue steroid-zwischenprodukte und verfahren zu ihrer herstellung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5502183A (de) |
| EP (1) | EP0624162B1 (de) |
| JP (1) | JPH07503466A (de) |
| AT (1) | ATE171186T1 (de) |
| AU (1) | AU3582393A (de) |
| CA (1) | CA2128860A1 (de) |
| DE (1) | DE69321099D1 (de) |
| WO (1) | WO1993015103A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060013750A1 (en) * | 2004-07-16 | 2006-01-19 | Martin Perry L | Solvent-activated reactor |
| JP4784402B2 (ja) * | 2006-06-06 | 2011-10-05 | 東ソー株式会社 | アリールアミン類製造用触媒およびそれを用いたアリールアミン類の製造方法 |
| EP3656385A1 (de) | 2008-05-28 | 2020-05-27 | ReveraGen BioPharma, Inc. | Nichthormonale steroide modulatoren von nf-kb zur behandlung von erkrankungen |
| HUE028327T2 (en) * | 2008-06-06 | 2017-02-28 | Neurmedix Inc | A process for the preparation of 17-alkynyl-7-hydroxy steroids and related compounds |
| EP2556083A4 (de) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | Nichthormonale steroide modulatoren von nf-kappa-b zur krankheitsbehandlung |
| WO2013092668A1 (en) | 2011-12-23 | 2013-06-27 | Crystal Pharma, S.A.U. | Process for alkynylating 16-substituted-17-keto steroids |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
| CN114230627B (zh) * | 2021-12-31 | 2023-09-15 | 湖南新合新生物医药有限公司 | 一种倍他米松环氧水解物中间体的制备方法 |
| CN121295207B (zh) * | 2025-12-11 | 2026-02-24 | 苏州大学 | 甾体化合物的定点氯代方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637670A (en) * | 1969-09-02 | 1972-01-25 | Syntex Corp | Intermediates and process for preparing useful 17alpha-hydroxy-20-keto and 17alpha 21-dihydroxy-20-keto pregnanes and derivatives thereof |
| US3681410A (en) * | 1970-08-07 | 1972-08-01 | Syntex Corp | Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof |
| DE2141127A1 (de) * | 1971-08-17 | 1973-03-01 | Syntex Corp | Neues verfahren zur herstellung wertvoller steroidderivate und zwischenprodukte fuer dieselben |
| US4059617A (en) * | 1976-04-29 | 1977-11-22 | American Cyanamid Company | Synthesis of dimethylaminoethyl methylmethacrylate |
| ES2052550T3 (es) * | 1986-10-10 | 1994-07-16 | Roussel Uclaf | 9-alfa-hidroxiesteroides, procedimiento para su preparacion y procedimiento para la preparacion de los correspondientes derivados 9(11)-deshidro. |
| ES2033516T3 (es) * | 1988-04-08 | 1993-03-16 | Roussel-Uclaf | Procedimiento para preparar 9 alfa-hidroxi-17 metileno-esteroides. |
| EP0523132A1 (de) * | 1990-03-27 | 1993-01-20 | Schering Corporation | Verfahren zur dehydrierung von 9-alpha-hydroxy-steroiden |
-
1993
- 1993-01-26 AT AT93904484T patent/ATE171186T1/de active
- 1993-01-26 CA CA002128860A patent/CA2128860A1/en not_active Abandoned
- 1993-01-26 US US08/256,812 patent/US5502183A/en not_active Expired - Fee Related
- 1993-01-26 JP JP5513255A patent/JPH07503466A/ja active Pending
- 1993-01-26 AU AU35823/93A patent/AU3582393A/en not_active Abandoned
- 1993-01-26 DE DE69321099T patent/DE69321099D1/de not_active Expired - Lifetime
- 1993-01-26 EP EP93904484A patent/EP0624162B1/de not_active Expired - Lifetime
- 1993-01-26 WO PCT/US1993/000211 patent/WO1993015103A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993015103A3 (en) | 1993-11-25 |
| US5502183A (en) | 1996-03-26 |
| JPH07503466A (ja) | 1995-04-13 |
| AU3582393A (en) | 1993-09-01 |
| EP0624162B1 (de) | 1998-09-16 |
| DE69321099D1 (de) | 1998-10-22 |
| CA2128860A1 (en) | 1993-08-05 |
| WO1993015103A2 (en) | 1993-08-05 |
| EP0624162A1 (de) | 1994-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH02167296A (ja) | １３‐エピステロイド | |
| ATE171186T1 (de) | Neue steroid-zwischenprodukte und verfahren zu ihrer herstellung | |
| ATE163423T1 (de) | Verfahren zur herstellung von taurocholansäure | |
| US2883401A (en) | 2,17-di-lower alkyl-testosterones | |
| CA1309088C (en) | 17.beta.-(CYCLOPROPYLOXY)ANDROST-5-EN-3.beta.-OL AND RELATED COMPOUNDS USEFUL ASC -- -LYASE INHIBITORS | |
| ATE14317T1 (de) | Verfahren zur herstellung von zwischenprodukten in der synthese von vitamin d3-metaboliten und neue zwischenprodukte. | |
| ATE16601T1 (de) | Steroidesters und verfahren zur herstellung von steroidesters. | |
| DE2529969A1 (de) | Neue von testosteron abgeleitete haptene, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von antigenen | |
| DE3127989A1 (de) | Neue 17(20)-ungesaettigte 20-isonitril-steroide, verfahren zu deren herstellung und ihre verwendung zur herstellung von 17(alpha)-hydroxy-20-keto-steroiden | |
| EP0440752B1 (de) | Verfahren zur herstellung von 3-desoxy-4-en-steroiden | |
| US2818408A (en) | Steroid compounds and process | |
| US2923722A (en) | 2-lower-alkyl-9alpha-halo-4-pregnenes | |
| US2842567A (en) | Therapeutically valuable esters of alcohols and ketoalcohols of the steroid series and process of preparing same | |
| US3729494A (en) | 7alpha-methylandrostenolones | |
| US3086033A (en) | 1-methyl-17-alkyl-11-oxygenated delta1, 3, 5 (10)-estrogenic compounds | |
| US2538731A (en) | Metal oxide treatment of 3-formoxy steroids | |
| US3160644A (en) | 1-dehydro-11-keto-9alpha-fluoro-17alpha-methyl testosterones | |
| DE2704130C2 (de) | ||
| US2844605A (en) | Organic compounds and process | |
| US2769825A (en) | Preparation of 17alpha-hydroxy-20-keto-pregnenes from delta-pregnenes | |
| JPS62223190A (ja) | １７α−プレグネン−カルボン酸メチルエステル化合物 | |
| US2868808A (en) | 11-oxygenated 17alpha, 21-dihydroxyallopregnan-20-one and esters thereof | |
| US3159620A (en) | Process for the preparation of 17 alpha-ethynyl-19-norandrostene compounds | |
| DE1543270A1 (de) | Verfahren zur Herstellung von delta?(10)-3-Desoxosteroiden | |
| US3471495A (en) | 6-oxygenated-3,4-diaza-delta**4-androstenes |